← Mechanisms of action
GPRC5D
SINGLE PROTEINHomo sapiens
Preferred name: G-protein coupled receptor family C group 5 member D ChEMBL ↗
Linked proteins
Drugs acting on this target (19)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| jnj-79635322 | Binding agent | experimental | mAb | binding agent - GPRC5D |
| Talquetamab (Talvey) | Binding agent | approved | mAb | G-protein coupled receptor family C group 5 member D binding agent |
| tqb2029 | Immunity, active | experimental | mAb | GPRC5D immunity, active |
| act-001 car-nk cell | Immunity, passive | experimental | Cell therapy | GPRC5D immunity, passive |
| bcma/gprc5d double car-t | Immunity, passive | experimental | Cell therapy | immunity, passive - gprc5d |
| chimeric antigen receptor t cell o&d-001 injection targeting bcma and gprc5d | Immunity, passive | experimental | Cell therapy | GPRC5D immunity, passive |
| ct071 | Immunity, passive | experimental | Cell therapy | GPRC5D immunity, passive |
| deeptag-gprc5d targeted car t-cells | Immunity, passive | experimental | Cell therapy | immunity, passive - gprc5d |
| gprc5d-car-t | Immunity, passive | experimental | Cell therapy | immunity, passive - gprc5d |
| mcarh109 | Immunity, passive | experimental | Cell therapy | immunity, passive - GPRC5D |
| mcarh109 t cells | Immunity, passive | experimental | Cell therapy | immunity, passive - GPRC5D |
| ol-101 | Immunity, passive | experimental | Cell therapy | GPRC5D immunity, passive |
| bms-986453 | Inhibitor | experimental | mAb | inhibitor - GPRC5D |
| gprc5d/cd3 bites | Inhibitor | experimental | mAb | GPRC5D inhibitor |
| ibi3003 | Inhibitor | experimental | mAb | inhibitor - GPRC5D |
| lbl-034 | Inhibitor | experimental | mAb | inhibitor - GPRC5D |
| qls32015 | Inhibitor | experimental | mAb | inhibitor - GPRC5D |
| sar446523 | Inhibitor | experimental | Small molecule | GPRC5D inhibitor |
| sim0500 | Inhibitor | experimental | mAb | GPRC5D inhibitor |